COMPANY INTELLIGENCEWhat the linked records show
MedtechLedger currently links 5 FDA records to the applicant name Anika Therapeutics, Inc.. The collection includes 2 510(k) clearances. 3 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Oct 15, 2025 to Sep 17, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code LZP appears in 2 of the 5 linked filings. The collection spans 4 FDA product codes and 2 original PMA application families. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P000046, with 2 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes. 2 linked filings have a current plain-language explanation checked against the recorded FDA decision.
Applicant mailing address recorded by FDA: 32 Wiggins Ave., Beford, MA, 01730, US. Recorded on K261869, decision dated Sep 17, 2026.
Device categories in this collection
Fastener, Fixation, Nondegradable, Soft Tissue; Absorbable Synthetic Wound Dressing; Aid, Surgical, Viscoelastic; Acid, Hyaluronic, Intraarticular.
Changes described in PMA records
FDA’s recorded scope: the replacement of reusable components with single-use, presterilized components for use during transfer steps of the formulation and fill process during manufacturing of the subject sodium hyaluronate devices
Aug 28, 2026 · 30-Day NoticeFDA’s recorded scope: the replacement of reusable components with single-use, presterilized components for use during transfer steps of the formulation and fill process during manufacturing of the subject sodium hyaluronate devices
Aug 28, 2026 · 30-Day NoticeFDA’s recorded scope: a replacement adhesive laminate film for the sealed pouch used as a sterile barrier system for the subject ophthalmic viscosurgical device
Oct 15, 2025 · 30-Day NoticeSubsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.